Understanding irregular heartbeats during pregnancy
Chukwuma I. Onyeije, MD · Maternal-Fetal Medicine
Any deviation from the normal fetal heart rate — in rate, regularity, or both.
Arrhythmias may arise from structural heart defects or primary electrical conduction issues in a structurally normal heart.
Reassuring perspective: The vast majority of fetal arrhythmias detected during routine prenatal care are premature atrial contractions — benign, self-limited, and requiring only monitoring.
| Category | Heart Rate | Common Examples | Clinical Risk |
|---|---|---|---|
| Irregular | Normal baseline with extra beats | Premature Atrial Contractions (PACs) | Very low (<1% progression) |
| Tachyarrhythmia | Persistently >160–180 bpm | SVT, Atrial Flutter | Moderate–high; hydrops risk |
| Bradyarrhythmia | Persistently <110 bpm | Complete AV Block (CAVB) | Variable; immune-mediated |
An extra heartbeat that originates in the upper chambers (atria) and fires earlier than expected — creating a brief irregularity in the rhythm.
PACs resolve spontaneously in the vast majority of cases as the fetal conduction system matures — often before or shortly after birth.
Approximately 0.4% of fetuses with PACs may develop a sustained tachyarrhythmia such as SVT or atrial flutter.
Weekly fetal heart rate assessment — via auscultation or ultrasound — until the rhythm resolves or delivery.
Occasionally associated with a redundant foramen ovale flap. Rarely linked to congenital heart defects (CHD).
A sustained fetal heart rate exceeding 160–180 bpm. Persistent tachycardia can impair cardiac output and lead to fetal heart failure.
SVT occurs in approximately 1 in 2,000 pregnancies and is the most clinically significant fetal tachyarrhythmia.
Persistent rapid heart rate reduces cardiac output, causing fluid to accumulate in fetal body cavities (abdomen, chest, skin). This is a serious complication requiring urgent intervention.
SVT features 1:1 AV conduction at 220–260 bpm. Atrial flutter has atrial rates of 300–500 bpm with variable AV block (often 2:1), resulting in a ventricular rate of ~150–250 bpm.
Transplacental antiarrhythmic therapy — using medications such as digoxin, flecainide, or sotalol — is highly effective, particularly when initiated before the onset of hydrops.
A sustained fetal heart rate below 110 bpm. The most severe form is Complete Atrioventricular Block (CAVB), in which the atria and ventricles beat independently.
CAVB occurs in approximately 1 in 20,000 live births. Approximately 50% of cases are associated with maternal autoimmune antibodies.
Atrial (P) and ventricular (V) activity are dissociated in CAVB
Serial fetal echocardiography to assess cardiac function, ventricular rate, and signs of hydrops.
Fluorinated corticosteroids (e.g., dexamethasone) are used in immune-mediated cases. Efficacy remains under evaluation in ongoing clinical trials.
Simultaneous visualization of atrial and ventricular wall motion — determines the relationship between contractions.
Evaluates blood flow in the superior vena cava and ascending aorta to measure AV intervals and mechanical conduction times.
Non-invasive recording of magnetic fields from fetal cardiac electrical activity — provides more precise electrophysiological data than ultrasound alone.
Important: Any fetus with a sustained tachyarrhythmia or bradyarrhythmia requires urgent referral to a tertiary care center for specialized echocardiography and potential intrauterine therapy.
| Arrhythmia | Primary Approach | Medications / Interventions |
|---|---|---|
| PACs | Weekly FHR monitoring; reassurance | No medication required in most cases |
| SVT / Atrial Flutter | Transplacental antiarrhythmic therapy | Digoxin, Flecainide, Sotalol (maternal administration) |
| CAVB | Serial fetal echocardiography | Dexamethasone (immune-mediated); neonatal pacemaker if indicated |
Management depends on arrhythmia type, gestational age at diagnosis, and the presence or absence of fetal hydrops. A multidisciplinary team — including MFM specialists and pediatric cardiologists — guides all treatment decisions.
The majority of fetal arrhythmias are PACs — benign and self-resolving.
Regular surveillance allows early detection of any progression.
Tachyarrhythmias respond well to transplacental medication therapy.
MFM specialists and pediatric cardiologists work together for your baby.
Questions are always welcome. Your care team is your partner throughout this journey.
Chukwuma I. Onyeije, MD · Maternal-Fetal Medicine